Tarbox Family Office, Inc. Sage Therapeutics, Inc. Transaction History

Tarbox Family Office, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$30.71 - $45.71 $767 - $1,142	-25 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$40.26 - $57.37 $120 - $172	-3 Reduced 10.71%	25 $1,000
Q2 2020 Jul 23, 2020	BUY	$25.95 - $43.15 $259 - $431	10 Added 55.56%	28 $1,000
Q1 2020 Apr 30, 2020	BUY	$26.15 - $77.24 $470 - $1,390	18 New	18 $1,000
Q4 2019 Jan 31, 2020	SELL	$60.18 - $154.77 $782 - $2,012	-13 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$89.33 - $163.65 $1,161 - $2,127	13 New	13 $2,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.